<a href="https://laohu8.com/S/FOXO">FOXO Technologies Inc.</a> Faces Delisting from NYSE American Due to Low Stock Price; Moves to OTC Market
FOXO Technologies Inc., a Delaware corporation, announced on August 12, 2025, that its Class A Common Stock will be delisted from the NYSE American due to its low selling price, which fell below the $0.10 minimum threshold. Trading was suspended immediately by NYSE. The company has since received confirmation from FINRA's Department of Market Operations that its stock will trade on the OTC market under the symbol "FOXO" starting August 13, 2025. Additionally, FOXO Technologies disclosed that its board of directors determined previous financial statements from its Quarterly Report ended March 31, 2025, should not be relied upon due to an error related to the accounting for purchase price consideration in connection with its acquisition of Rennova Community Health, Inc. The company plans to amend its financial statements to address this issue.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-024660), on August 18, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。